-
21
Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL
Published 2021“…American Society of Hematology…”
Journal article -
22
CD34+CD19-CD22+ B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies
Published 2022“…American Society of Hematology…”
Journal article -
23
Variable cells with identical genetic codes
Published 2020“…American Society of Hematology…”
Journal article -
24
SCL/TAL1: a multifaceted regulator from blood development to disease
Published 2017“…American Society of Hematology…”
Journal article -
25
Natural killer T cells accelerate atherogenesis in mice
Published 2004“…American Society of Hematology…”
Journal article -
26
Trisomy 21 driven pro-inflammatory signalling in fetal bone marrow may play a role in perturbed B-lymphopoiesis and acute lymphoblastic leukemia of Down syndrome
Published 2019“…American Society of Hematology…”
Conference item -
27
Passive immune therapies: another tool against COVID-19
Published 2021“…American Society of Hematology…”
Journal article -
28
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.
Published 2014“…American Society of Hematology…”
Journal article -
29
Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway
Published 2017“…American Society of Hematology…”
Journal article -
30
Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
Published 2018“…American Society of Hematology…”
Conference item -
31
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG mice
Published 2020“…American Society of Hematology…”
Journal article -
32
Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome.
Published 2010“…American Society of Hematology…”
Journal article -
33
Vorinostat does not improve outcome in patients with acute myeloid leukemia and high risk myelodysplasia treated with azacitidine: Results of the UK Trials Acceleration Programme R...
Published 2016“…American Society of Hematology…”
Conference item -
34
Physioxia improves the selectivity of hematopoietic stem cell expansion cultures
Published 2023“…American Society of Hematology…”
Journal article -
35
A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3.
Published 2014“…American Society of Hematology…”
Journal article -
36
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial
Published 2023“…American Society of Hematology…”
Journal article -
37
Sickle cell disease: the price of cure
Published 2016“…American Society of Hematology…”
Journal article -
38
A tale of two alleles: TP53 and transformation in MPNs
Published 2022“…American Society of Hematology…”
Journal article -
39
Health-related quality of life (HRQoL) during treatment with enasidenib (ENA) plus azacitidine (AZA) in patients with newly diagnosed mutant IDH2 (m IDH2) acute myeloid leukemia (A...
Published 2021“…American Society of Hematology…”
Conference item -
40
Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003.
Published 2014“…American Society of Hematology…”
Journal article